Pathological Complete Response with Platinum Containing Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: An Interventional Study

Pathological Complete Response with Platinum Containing Neoadjuvant Chemotherapy in Triple-negative Breast Cancer: An Interventional Study

Introduction: Triple-negative Breast Cancer (TNBC) accounts for 20% of all breast cancer cases globally and responds well to cytotoxic chemotherapy. The standard Neoadjuvant Chemotherapy (NAC) regimen for TNBC includes 4+4 cycles of anthracycline, cyclophosphamide, and taxane. Integrating platinum a...

Full description

Bibliographic Details
Main Authors: Binila Mary Jose, VR Ajith Kumar, Suma Susan Meloot
Format: Article
Language:English
Published: JCDR Research and Publications Private Limited 2024-04-01
Series:Journal of Clinical and Diagnostic Research
Subjects:
breast neoplasms
carboplatin
response evaluation criteria in solid tumours
Online Access:https://www.jcdr.net/articles/PDF/19320/65849_CE[Ra1]_F[SK]_QC_REF_PAT(SHK_IS)_PF1(VD_DK_OM)_PFA(VD_KM)_PN(KM).pdf

Internet

https://www.jcdr.net/articles/PDF/19320/65849_CE[Ra1]_F[SK]_QC_REF_PAT(SHK_IS)_PF1(VD_DK_OM)_PFA(VD_KM)_PN(KM).pdf

Similar Items